November 1, 2002Journal of the American Society of Nephrology
The Renin-Angiotensin System as a Risk Factor and Therapeutic Target for Cardiovascular and Renal Disease
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports RAS inhibition across CV/renal diseases; leaves open optimal integration with contemporary therapies in diverse populations.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Volpe et al. (2002) studied this question.